Clinical Genomics Market, By Product and Service (Instruments or Systems (Sequencers, PCR Systems, Microarray Scanners, Automated Liquid Handlers, Other Genomic Analyzers), and Consumables (Reagents and Kits, Software and Services), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray , Sanger Sequencing, and Other Technologies (e.g., FISH, Karyotyping)), By Application (Oncology (Cancer Diagnosis and Prognosis, Therapy Selection and Companion Diagnostics, Hereditary Cancer Risk Assessment, Minimal Residual Disease (MRD) Monitoring, Liquid Biopsy Analysis), Infectious Diseases (Pathogen Identification and Characterization (Bacterial, Viral, Fungal, Parasitic), Genetic Disorders, Cardiovascular Diseases, Neurological Disorders, and Other Applications (Pharmacogenomics, etc.)), By End User (Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, and Others (Academic and Research Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)